Latest News and Press Releases

VANCOUVER, BC, April 30, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-thermal, non-tumescent ("NT-NT") solutions for venous...

~ Submission of a UK Marketing Authorization Application for AMT-130 is expected in the third quarter of 2026 ~ ~ Type B Meeting with U.S. FDA granted in second quarter; expect to discuss potential...

White Oak, Md., April 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced results from the largest and most rigorous examination ever conducted focused on chemical...

The FDA is making AI part of the R&D core infrastructure and companies like Totaligent (OTCID: TGNT) are building the “picks-and-shovels” layer of biotech

White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical...

Oncolytics Biotech announced Type C meeting with the FDA aligning on the design of clinical study to support approval of pelareorep in patients with SCAC.

 – Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing...

Freiburg, Germany, April 23, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle...

TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company...

CEO Gareth Sheridan appears as guest on the Jack Neel Podcast